AU2003266283B2 - Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate - Google Patents

Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate Download PDF

Info

Publication number
AU2003266283B2
AU2003266283B2 AU2003266283A AU2003266283A AU2003266283B2 AU 2003266283 B2 AU2003266283 B2 AU 2003266283B2 AU 2003266283 A AU2003266283 A AU 2003266283A AU 2003266283 A AU2003266283 A AU 2003266283A AU 2003266283 B2 AU2003266283 B2 AU 2003266283B2
Authority
AU
Australia
Prior art keywords
extrudate
silicic acid
acid
carrier
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2003266283A
Other languages
English (en)
Other versions
AU2003266283A1 (en
Inventor
Dirk Andre Richard Vanden Berghe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Minerals NV
Original Assignee
Bio Minerals NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Minerals NV filed Critical Bio Minerals NV
Publication of AU2003266283A1 publication Critical patent/AU2003266283A1/en
Application granted granted Critical
Publication of AU2003266283B2 publication Critical patent/AU2003266283B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
AU2003266283A 2002-08-12 2003-08-12 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate Expired AU2003266283B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02078336A EP1391426A1 (en) 2002-08-12 2002-08-12 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
EP02078336.1 2002-08-12
PCT/EP2003/009009 WO2004016551A1 (en) 2002-08-12 2003-08-12 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate

Publications (2)

Publication Number Publication Date
AU2003266283A1 AU2003266283A1 (en) 2004-03-03
AU2003266283B2 true AU2003266283B2 (en) 2008-04-10

Family

ID=30775855

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003266283A Expired AU2003266283B2 (en) 2002-08-12 2003-08-12 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate

Country Status (15)

Country Link
US (2) US8771757B2 (cg-RX-API-DMAC7.html)
EP (2) EP1391426A1 (cg-RX-API-DMAC7.html)
JP (2) JP4727227B2 (cg-RX-API-DMAC7.html)
CN (2) CN101829143A (cg-RX-API-DMAC7.html)
AT (1) ATE428404T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003266283B2 (cg-RX-API-DMAC7.html)
CA (1) CA2494165C (cg-RX-API-DMAC7.html)
CY (1) CY1109228T1 (cg-RX-API-DMAC7.html)
DE (1) DE60327231D1 (cg-RX-API-DMAC7.html)
DK (1) DK1551763T3 (cg-RX-API-DMAC7.html)
ES (1) ES2325254T3 (cg-RX-API-DMAC7.html)
IL (2) IL166779A0 (cg-RX-API-DMAC7.html)
PT (1) PT1551763E (cg-RX-API-DMAC7.html)
SI (1) SI1551763T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004016551A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1391426A1 (en) 2002-08-12 2004-02-25 Bio Minerals N.V. Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
ITMI20050093A1 (it) * 2005-01-25 2006-07-26 Unimer Spa Procedimento industriale per ottenere la granulazione di fertilizzanti mangimi e altri prodotti a partire da un procedimento preliminare di pellettatura
US7700083B2 (en) * 2005-10-24 2010-04-20 Kevin Meehan Skin care composition for accelerated production of collagen proteins and method of fabricating same
FR2909558B1 (fr) * 2006-12-12 2009-04-17 Ceva Sante Animale Sa Procede de fabrication de premelanges medicamenteux
ES2652114T3 (es) * 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
GB0720423D0 (en) * 2007-10-19 2007-11-28 Univ Leuven Kath Method for brewing beer
GB0805279D0 (en) 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2009127256A1 (en) * 2008-04-17 2009-10-22 Jisbrey, S.A Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use
CZ2008841A3 (cs) * 2008-12-23 2010-07-28 Agra Group, A.S. Pivo a nápoje na bázi piva a zpusob úpravy obsahu polyfenolu a kremíku v nich
GB0913255D0 (en) 2009-07-30 2009-09-02 Sisaf Ltd Topical composition
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010008982A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
WO2012032364A1 (en) 2010-09-06 2012-03-15 Creogen D.O.O. Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
US10986647B2 (en) 2017-05-04 2021-04-20 At&T Intellectual Property I, L.P. Management of group common downlink control channels in a wireless communications system
CN107988292B (zh) * 2018-01-18 2023-12-26 江苏江山聚源生物技术有限公司 提高重组人源胶原蛋白稳定性的发酵工艺
EP3549578A1 (en) * 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
EP3632449A1 (en) 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
EP3650011A1 (en) * 2018-11-09 2020-05-13 Bio Minerals NV Water soluble silicon-containing granulate
PL3662761T3 (pl) * 2018-12-04 2021-11-02 Dsm Ip Assets B.V. Stabilne podczas przechowywania adsorbaty związków nitrooksy
EP3714879A1 (en) 2019-03-28 2020-09-30 Sisaf Ltd Structured encapsulated silicon-containing particles
GB201904337D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd A delivery system
GB201904334D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd Carrier system for preparing herbaceous extracts
GB201904336D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd A delivery system
WO2020260413A1 (fr) 2019-06-28 2020-12-30 Tilman Sa Composition comprenant au moins un triterpène et/ou au moins un triterpénoïde et/ou au moins une de leurs formes glycosylées
GB202104173D0 (en) * 2021-03-24 2021-05-05 Ab Vista Animal feed composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922360A (en) * 1994-02-07 1999-07-13 Bio Pharma Sciences B.V. Stabilized orthosilicic acid comprising preparation and biological preparation
EP1110909A1 (en) * 1999-12-24 2001-06-27 Bio Minerals N.V. Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
US6335457B1 (en) * 1999-10-15 2002-01-01 Exsymol S.A.M. Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1391426A1 (en) 2002-08-12 2004-02-25 Bio Minerals N.V. Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922360A (en) * 1994-02-07 1999-07-13 Bio Pharma Sciences B.V. Stabilized orthosilicic acid comprising preparation and biological preparation
US6335457B1 (en) * 1999-10-15 2002-01-01 Exsymol S.A.M. Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex
EP1110909A1 (en) * 1999-12-24 2001-06-27 Bio Minerals N.V. Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use

Also Published As

Publication number Publication date
US20060099276A1 (en) 2006-05-11
AU2003266283A1 (en) 2004-03-03
CA2494165A1 (en) 2004-02-26
CN101829143A (zh) 2010-09-15
US20140255493A1 (en) 2014-09-11
US8945617B2 (en) 2015-02-03
EP1391426A1 (en) 2004-02-25
JP4727227B2 (ja) 2011-07-20
CN1678524A (zh) 2005-10-05
DE60327231D1 (de) 2009-05-28
SI1551763T1 (sl) 2009-10-31
WO2004016551A1 (en) 2004-02-26
CY1109228T1 (el) 2014-07-02
EP1551763B1 (en) 2009-04-15
JP2010265309A (ja) 2010-11-25
US8771757B2 (en) 2014-07-08
PT1551763E (pt) 2009-07-07
EP1551763A1 (en) 2005-07-13
ES2325254T3 (es) 2009-08-31
DK1551763T3 (da) 2009-07-20
JP2005535549A (ja) 2005-11-24
CA2494165C (en) 2009-05-26
IL166779A (en) 2010-05-17
ATE428404T1 (de) 2009-05-15
IL166779A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
US8945617B2 (en) Extrudate and methods of using said extrudate
AU783216B2 (en) Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
CN101983064B (zh) 吸收性可摄入剂以及相关的制备和使用方法
JP2005535549A5 (cg-RX-API-DMAC7.html)
CN1085081A (zh) 药物及其它剂型
CN1202130C (zh) 呈固态、稳定和浓缩形式的基于可生物吸收原硅酸的络合物及其制备方法
CN1155417A (zh) S(+)-布洛芬的口服制剂
CN1728987A (zh) 可食用的磷蛋白薄膜
CN101765426A (zh) 服用感优异的含氨基酸颗粒制剂
TW202028330A (zh) 水溶性含矽顆粒
CN1188133C (zh) 补充能量的糖源及其应用
JP2001524090A (ja) ペプチド、タンパク質および核酸を投与するための安定製剤形態
JP3881453B2 (ja) カルシウム吸収促進剤およびその製造方法
US20210046010A1 (en) Tablets containing arginine at high concentration
JPWO2009028649A1 (ja) アミノ酸高含量固形製剤の低容量化製法
CN100486990C (zh) 一种谷胱甘肽螯合钙及其制备方法,用途和组合物
JPH0678226B2 (ja) 脱水医薬品とその製造方法
CN121400581A (zh) 酶解法制备高活性海洋生物肽及其在食品中的应用
KR20250106864A (ko) 단백질 가수분해물을 포함한 구강붕해정의 제조 방법 및 이 방법에 의해 제조된 구강붕해정
RU2054933C1 (ru) Препарат для профилактики и лечения желудочно-кишечных болезней новорожденных телят
JPS62281847A (ja) アミノ酸組成物
JPS62126118A (ja) 脱水医薬品とその製造方法
CN1747717A (zh) 包含多糖组分和一个或多个涂层的组合物
CN1552444A (zh) 含母乳型氨基酸与超氧化物歧化酶结合物及制备方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired